PL3006022T3 - Osmolity do leczenia wirusowych chorób układu oddechowego - Google Patents

Osmolity do leczenia wirusowych chorób układu oddechowego

Info

Publication number
PL3006022T3
PL3006022T3 PL15189573T PL15189573T PL3006022T3 PL 3006022 T3 PL3006022 T3 PL 3006022T3 PL 15189573 T PL15189573 T PL 15189573T PL 15189573 T PL15189573 T PL 15189573T PL 3006022 T3 PL3006022 T3 PL 3006022T3
Authority
PL
Poland
Prior art keywords
respiratory diseases
osmolytes
treatment
viral respiratory
viral
Prior art date
Application number
PL15189573T
Other languages
English (en)
Inventor
Jean Krutmann
Georg Lentzen
Thomas Schwarz
Original Assignee
Bitop Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bitop Ag filed Critical Bitop Ag
Publication of PL3006022T3 publication Critical patent/PL3006022T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
PL15189573T 2007-08-27 2008-08-25 Osmolity do leczenia wirusowych chorób układu oddechowego PL3006022T3 (pl)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
DE102007040615A DE102007040615A1 (de) 2007-08-27 2007-08-27 Osmolyte zur Behandlung von allergisch oder viral bedingten Atemwegserkrankungen
PCT/EP2008/006959 WO2009027069A2 (de) 2007-08-27 2008-08-25 Osmolyte zur behandlung von allergisch oder viral bedingten atemwegserkrankungen
EP15189573.7A EP3006022B1 (de) 2007-08-27 2008-08-25 Osmolyte zur behandlung von viral bedingten atemwegserkrankungen
EP11004754.5A EP2380569B1 (de) 2007-08-27 2008-08-25 Osmolyte zur Reduzierung der Nebenwirkungen von Steroiden oder Antihistaminika
EP08801690A EP2200603B1 (de) 2007-08-27 2008-08-25 Osmolyte zur behandlung von allergisch bedingten atemwegserkrankungen

Publications (1)

Publication Number Publication Date
PL3006022T3 true PL3006022T3 (pl) 2022-03-28

Family

ID=40298861

Family Applications (3)

Application Number Title Priority Date Filing Date
PL11004754T PL2380569T3 (pl) 2007-08-27 2008-08-25 Osmolity do zmniejszania niepożądanych działań steroidów lub leków przeciwhistaminowych
PL08801690T PL2200603T3 (pl) 2007-08-27 2008-08-25 Osmolity do leczenia alergicznych chorób oddechowych
PL15189573T PL3006022T3 (pl) 2007-08-27 2008-08-25 Osmolity do leczenia wirusowych chorób układu oddechowego

Family Applications Before (2)

Application Number Title Priority Date Filing Date
PL11004754T PL2380569T3 (pl) 2007-08-27 2008-08-25 Osmolity do zmniejszania niepożądanych działań steroidów lub leków przeciwhistaminowych
PL08801690T PL2200603T3 (pl) 2007-08-27 2008-08-25 Osmolity do leczenia alergicznych chorób oddechowych

Country Status (15)

Country Link
US (1) US8765691B2 (pl)
EP (4) EP3006022B1 (pl)
JP (1) JP2010536904A (pl)
KR (1) KR101638637B1 (pl)
AT (1) ATE514422T1 (pl)
AU (1) AU2008291302B2 (pl)
CA (2) CA2942021C (pl)
DE (1) DE102007040615A1 (pl)
DK (1) DK2380569T3 (pl)
ES (3) ES2902827T3 (pl)
HU (1) HUE043920T2 (pl)
PL (3) PL2380569T3 (pl)
PT (1) PT2380569T (pl)
TR (1) TR201908270T4 (pl)
WO (1) WO2009027069A2 (pl)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9089568B2 (en) * 2005-03-12 2015-07-28 Bitop Ag Method of using compatible solutes containing ectoine and/or hydroxyectoine
DE102008036725B4 (de) * 2008-08-07 2021-01-28 Maria Clementine Martin Klosterfrau Vertriebsgesellschaft Mbh Pharmazeutische Zusammensetzung für die nasale Applikation
DE102008039231A1 (de) * 2008-08-22 2010-02-25 Bitop Ag Verwendung von Glucosylglycerol
DE102011113059A1 (de) * 2011-09-09 2013-03-14 Bitop Ag Therapeutische Anwendungen von Ectoin
JP5960720B2 (ja) 2011-11-24 2016-08-02 東洋精糖株式会社 角結膜保護剤または角結膜障害抑制剤
DE202014105553U1 (de) * 2014-08-18 2015-08-20 Maria Clementine Martin Klosterfrau Vertriebsgesellschaft Mbh Cineolhaltige Zusammensetzung für die nasale Applikation
DE102015121050A1 (de) * 2015-12-03 2017-06-08 Bitop Ag Kompatibles Solut oder Solutgemisch zur Verwendung bei der Prävention oder Behandlung von Krankheiten mit Barrieredefekten in Epithelgeweben
DE102016125378A1 (de) * 2016-12-22 2018-06-28 Werner Schmidt Zusammensetzung zur Behandlung von Erkältungskrankheiten

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4305936A (en) * 1980-10-09 1981-12-15 Dermik Laboratories Topical corticosteroid formulations
DE3635522A1 (de) * 1986-10-18 1988-04-28 Euro Celtique Sa Pharmazeutische zusammensetzung
FR2674434B1 (fr) * 1991-03-27 1993-06-18 Nativelle Sa Ets Nouvelle composition pharmaceutique a base de taurine pour l'administration par inhalation.
US5876780A (en) * 1993-04-29 1999-03-02 Cultor, Ltd. Compositions for treating coccidiosis
US5880098A (en) * 1996-04-12 1999-03-09 Pharmacia & Upjohn Aktiebolag Therapeutic treatment
PT101887A (pt) * 1996-06-28 1998-01-30 Inst De Biolog Ex E Tecnologic Utilizacao de 2-0- -manosilglicerato para termoestabilizacao, osmoproteccao e proteccao contra a desidratacao de enzimas, outros componenetes celulares e celulas
US20010056068A1 (en) * 1998-03-04 2001-12-27 Kristof Chwalisz Method of treatment and prevention of nitric oxide deficiency-related disorders with citrulline and citrulline derivatives
AU750027B2 (en) * 1998-08-01 2002-07-11 Merck Patent Gmbh Use of ectoine or ectoine derivatives in cosmetic formulations
CA2356637C (en) * 1998-12-22 2011-09-13 The University Of North Carolina At Chapel Hill Compounds and methods for the treatment of airway diseases and for the delivery of airway drugs
ATE247981T1 (de) * 1999-06-12 2003-09-15 Bitop Ag Proteinenthaltende pharmazeutische zubereitung
EP1272201B1 (de) * 2000-04-12 2004-11-24 Bitop Aktiengesellschaft Für Biotechnische Optimierung Verwendung von kompatiblen soluten als substanzen mit radikalfangenden eigenschaften
DE10040933A1 (de) * 2000-08-18 2002-03-07 Bitop Gmbh Verwendung von beta-Mannosylglycerat (Firoin) und/oder Derivaten, insbesondere dem beta-Mannosylglyceramid (Firoin-A), in kosmetischen und dermatologischen Formulierungen
US20040028631A1 (en) * 2000-08-18 2004-02-12 Thomas Schwarz Cosmetic formulations
DE10044985B4 (de) * 2000-09-11 2019-08-14 Merck Patent Gmbh Verwendung von Ectoin oder Ectoin-Derivaten zum Schutz vor Allergenen
EP1322308A2 (en) * 2000-10-06 2003-07-02 Durect Corporation Devices and methods for management of inflammation
US20020151541A1 (en) * 2000-10-31 2002-10-17 Michel Pairet Pharmaceutical compositions containing tiotropium salts and antihistamines and their use
DE10330243A1 (de) * 2003-07-03 2005-01-20 bitop Aktiengesellschaft für biotechnische Optimierung Verwendung von aus extremophilen Bakterien gewonnenen Osmolyten zur Herstellung von Arzneimitteln zur äusserlichen Behandlung der Neurodermitis
DE10330768A1 (de) * 2003-07-07 2005-02-24 bitop Aktiengesellschaft für biotechnische Optimierung Verwendung von aus extremophilen Bakterien gewonnenen Osmolyten zur Herstellung von inhalierbaren Arzneimitteln zur Prophylaxe und Behandlung pulmonaler und kardiovaskulärer Erkrankungen, sowie eines Osmolyte als Wirkstoffbestandteil enthaltende Inhalationsvorrichtung
JP4780907B2 (ja) * 2003-09-30 2011-09-28 小林製薬株式会社 催眠剤組成物
DE102004049062A1 (de) * 2004-03-30 2005-10-13 bitop Aktiengesellschaft für biotechnische Optimierung Topische Zubereitung zur Anwendung auf der Haut enthaltend natürliches Öl der Nachtkerze (Oenothera biennis) (=Oleum Oenothera) und Osmolyte aus extremophilen Mikroorganismen
US9089568B2 (en) * 2005-03-12 2015-07-28 Bitop Ag Method of using compatible solutes containing ectoine and/or hydroxyectoine
CN100431559C (zh) * 2005-12-08 2008-11-12 王金政 一种治疗感冒的药物及制备方法
US20110195973A1 (en) * 2006-06-09 2011-08-11 Parion Sciences, Inc. Cyclic substituted pyrazinoylguanidine sodium channel blockers possessing beta agonist activity
ES2392999T3 (es) * 2006-06-09 2012-12-17 Parion Sciences, Inc. Bloqueadores de canales de sodio pirazinoilguanidina sustituida con fenilo que tienen actividad agonista beta
AR062741A1 (es) * 2006-09-07 2008-12-03 Hirsh Andrew J Metodo para aumentar la hidratacion de la mucosa y la evacuacion de l a mucosa mediante tratamiento con bloquadores de los canales del sodio y osmolitos
DE102006056766A1 (de) * 2006-12-01 2008-06-05 Bitop Ag Verwendung von kompatiblen Soluten

Also Published As

Publication number Publication date
US20110053896A1 (en) 2011-03-03
CA2942021A1 (en) 2009-03-05
DE102007040615A1 (de) 2009-03-05
PL2200603T3 (pl) 2011-12-30
ES2730106T3 (es) 2019-11-08
CA2942021C (en) 2020-11-03
EP3006022A1 (de) 2016-04-13
EP3006022B1 (de) 2021-10-13
EP2380569B1 (de) 2019-03-13
TR201908270T4 (tr) 2019-06-21
HUE043920T2 (hu) 2019-09-30
EP2380569A2 (de) 2011-10-26
PL2380569T3 (pl) 2019-09-30
EP2200603A2 (de) 2010-06-30
EP2200603B1 (de) 2011-06-29
AU2008291302B2 (en) 2014-03-20
EP2380569A3 (de) 2012-06-27
KR101638637B1 (ko) 2016-07-11
WO2009027069A3 (de) 2009-04-30
DK2380569T3 (da) 2019-06-17
ATE514422T1 (de) 2011-07-15
WO2009027069A2 (de) 2009-03-05
AU2008291302A1 (en) 2009-03-05
CA2698135C (en) 2016-11-08
JP2010536904A (ja) 2010-12-02
ES2370955T3 (es) 2011-12-26
ES2902827T3 (es) 2022-03-30
PT2380569T (pt) 2019-06-25
KR20100075435A (ko) 2010-07-02
CA2698135A1 (en) 2009-03-05
US8765691B2 (en) 2014-07-01
EP3482755A1 (de) 2019-05-15

Similar Documents

Publication Publication Date Title
PL3006022T3 (pl) Osmolity do leczenia wirusowych chorób układu oddechowego
MX2013013809A (es) Dispositivos expandibles con revestimiento de una composicion de paclitaxel.
WO2005087253A3 (en) Interferon-beta for anti-virus therapy for respiratory diseases
CA2474479A1 (en) Composition for inhalation
PH12013501790B1 (en) Use of dpp iv inhibitors
EP2108390A3 (en) Device for local and/or regional delivery employing liquid formulations of therapeutic agents
WO2013019830A3 (en) Microfluidic drug delivery devices
ATE456369T1 (de) Flibanserin zur behandlung von harninkontinenz und assoziierten erkrankungen
WO2005058935A3 (en) Aqueous suspensions of ciclesonide for nebulisation
GB0620385D0 (en) Novel compounds
JP2007513993A5 (pl)
WO2011085256A3 (en) Treatment of obstructive sleep apnea syndrome with a combination of a carbonic anhydrase inhibitor and an additional active agent
WO2008148573A3 (de) Arzeimittel mit einer wirkstoffkombination enthaltend pantothensäure oder deren derivate zur behandlung von allergischen symptomen
WO2007023072A3 (en) Use of ambroxol for the treatment of rhinovirus infections
WO2010042701A3 (en) Corticosteroid compositions for use in treating diseases of the upper and lower airway passages
WO2011056871A3 (en) Rhamnolipid mechanism
MX2013013808A (es) Dispositivos expandibles con revestimiento de una composicion de rapamicina.
WO2008043788A3 (en) Novel compounds
WO2007139936A3 (en) Hyperthermic technologies comprising carbon micro- or nanotubes and therapeutic uses thereof
WO2008046407A3 (de) Verwendung von deuteriumdioxid zur behandlung von hyperproliferativen erkrankungen der haut
WO2007035879A3 (en) Combination s-nitrosothiol-based pharmaceutical products for restoring normal breathing rhythm
WO2009047788A3 (en) Topical composition containing the combination of mupirocin and beclomethasone
Lee Topical irrigations for chronic rhinosinusitis
CY1108501T1 (el) Συνθεση δια την προληψη και θεραπευτικη αγωγη ασθενειων κρυολογηματος
NZ597657A (en) Use sulphur particles less than 300 microns and sodium lignin sulfonate for treating diseases casused by microbial pathogenic infections